PGAM1 and nonpapillary renal cell carcinoma: Strikingly, Kaplan-Meier analysis revealed that patients with elevated PGAM1 immunohistochemical scores had a shorter overall survival time (Figure 2G), underscoring the potential clinical significance of PGAM1 in ccRCC.